The University of Chicago Header Logo
Last Name


Sajan Nagpal to Diabetes Mellitus, Type 2

This is a "connection" page, showing publications Sajan Nagpal has written about Diabetes Mellitus, Type 2.

Connection Strength
  1. Nagpal SJS, Kandlakunta H, Her T, Sharma A, Sannapaneni S, Smyrk TC, Velamala P, Garg SK, Rakshit K, Majumder S, Chari S, Matveyenko A. Pancreatic ductal adenocarcinoma is associated with a unique endocrinopathy distinct from type 2 diabetes mellitus. Pancreatology. 2020 Jul; 20(5):929-935.
    View in: PubMed
    Score: 0.474
  2. Nagpal SJS, Bamlet WR, Kudva YC, Chari ST. Comparison of Fasting Human Pancreatic Polypeptide Levels Among Patients With Pancreatic Ductal Adenocarcinoma, Chronic Pancreatitis, and Type 2 Diabetes Mellitus. Pancreas. 2018 07; 47(6):738-741.
    View in: PubMed
    Score: 0.416
  3. Nagpal SJ, Lopez R, Feldstein AE, Alkhouri N. Serum cytokeratin-18 fragment levels predict development of type 2 diabetes mellitus in adult patients with NAFLD. Liver Int. 2015 Dec; 35(12):2621.
    View in: PubMed
    Score: 0.335
  4. Nagpal SJS, Chari ST. Immunoglobulin G4 Levels. JAMA. 2019 Jan 15; 321(2):202-203.
    View in: PubMed
    Score: 0.108
  5. Sharma A, Kandlakunta H, Nagpal SJS, Feng Z, Hoos W, Petersen GM, Chari ST. Model to Determine Risk of Pancreatic Cancer in Patients With New-Onset Diabetes. Gastroenterology. 2018 09; 155(3):730-739.e3.
    View in: PubMed
    Score: 0.104
  6. Sah RP, Nagpal SJ, Mukhopadhyay D, Chari ST. New insights into pancreatic cancer-induced paraneoplastic diabetes. Nat Rev Gastroenterol Hepatol. 2013 Jul; 10(7):423-33.
    View in: PubMed
    Score: 0.072
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.